AE Wealth Management’s Royalty Pharma RPRX Stock Holding History

AE Wealth Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.66M	Buy	+29,628	New	+$1.54M	0.01%	725
2026 Q1	–	Sell	-26,050	Closed	-$1.01M	–	2686
2025 Q4	$1.01M	Buy	26,050 +929	+4%	+$35.4K	0.01%	798
2025 Q3	$886K	Sell	25,121 -29,078	-54%	-$1.05M	0.01%	787
2025 Q2	$1.95M	Sell	54,199 -858	-2%	-$28.4K	0.01%	545
2025 Q1	$1.71M	Sell	55,057 -3,245	-6%	-$103K	0.01%	565
2024 Q4	$1.49M	Sell	58,302 -475	-0.8%	-$12.6K	0.01%	615
2024 Q3	$1.66M	Sell	58,777 -4,221	-7%	-$117K	0.02%	586
2024 Q2	$1.66M	Buy	+62,998	New	+$1.75M	0.02%	572

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AE Wealth Management's RPRX Position: Q2 2026 in Review

AE Wealth Management opened a new position in Royalty Pharma (RPRX) in Q2 2026: 29,628 shares worth $1.66M. The stake represents 0.01% of the portfolio and ranks #725 among its holdings. This is a return to the name: AE Wealth Management previously reported a position in RPRX as recently as Q4 2025.

AE Wealth Management first reported a position in RPRX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.95M in Q2 2025. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

AE Wealth Management held 29,628 shares of Royalty Pharma worth $1.66M as of Q2 2026.
Royalty Pharma was a new AE Wealth Management position in Q2 2026.
Royalty Pharma made up 0.01% of AE Wealth Management's portfolio in Q2 2026, its #725 holding.
AE Wealth Management first reported a position in Royalty Pharma in Q2 2024 and has held it in 8 quarters since.
AE Wealth Management's Royalty Pharma position peaked at $1.95M in Q2 2025.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.